Evolute® Punctal Plug Delivery System
Glaucoma / Ocular Hypertension
UnknownActive
Key Facts
About Mati Therapeutics
Mati Therapeutics is pioneering a novel drug delivery approach in ophthalmology with its Evolute® Punctal Plug Delivery System, a small, cosmetically invisible device inserted into the tear duct. This platform aims to solve the critical problem of poor adherence to topical eye drop regimens, a major issue in managing chronic diseases like glaucoma. The company is led by founders with extensive experience from major ophthalmic players like Allergan and Abbott. Mati is positioned to address a significant unmet need in a large global market of patients with vision impairment from treatable causes.
View full company profileTherapeutic Areas
Other Glaucoma / Ocular Hypertension Drugs
| Drug | Company | Phase |
|---|---|---|
| BTQ 1902 | Novaliq | Phase 2 |
| iDose® TR (travoprost implant) | Glaukos | Commercial Launch |
| OTX-TIC | Ocular Therapeutix | Phase 1 |